BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2458308)

  • 1. Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease.
    Ray MB; Mendenhall CL; French SW; Gartside PS
    Hepatology; 1988; 8(5):1019-26. PubMed ID: 2458308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile duct changes in alcoholic liver disease. The Veterans Administration Cooperative Study Group.
    Ray MB; Mendenhall CL; French SW; Gartside PS
    Liver; 1993 Feb; 13(1):36-45. PubMed ID: 7681137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution patterns of cytokeratin antigen determinants in alcoholic and nonalcoholic liver diseases.
    Ray MB
    Hum Pathol; 1987 Jan; 18(1):61-6. PubMed ID: 2434406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.
    Van Eyken P; Sciot R; Desmet VJ
    Histopathology; 1988 Dec; 13(6):605-17. PubMed ID: 2466751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease.
    Gonzalez-Quintela A; Mella C; Abdulkader I; Perez LF; Campos J; Otero E; Forteza J
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1413-8. PubMed ID: 15365314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275.
    Chedid A; Mendenhall CL; Moritz TE
    Arch Pathol Lab Med; 1999 May; 123(5):411-4. PubMed ID: 10235499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The common pattern of cytokeratin alteration in alcoholic and cholestatic liver disease is different from that of hepatitic liver damage. A study with the panepithelial monoclonal antibody lu-5.
    Müllhaupt B; Gudat F; Epper R; Bianchi L
    J Hepatol; 1993 Aug; 19(1):23-35. PubMed ID: 7507954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver.
    Katsuma Y; Swierenga SH; Khettry U; Marceau N; French SW
    Hepatology; 1987; 7(6):1215-23. PubMed ID: 2445643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study.
    Van Eyken P; Sciot R; Callea F; Van der Steen K; Moerman P; Desmet VJ
    Hepatology; 1988; 8(6):1586-95. PubMed ID: 2461337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease.
    Burt AD; Stewart JA; Aitchison M; MacSween RN
    J Clin Pathol; 1987 Jul; 40(7):719-24. PubMed ID: 2442199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study.
    Van Eyken P; Sciot R; Desmet V
    Lab Invest; 1988 Jul; 59(1):52-9. PubMed ID: 2455831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient.
    van Eyken P; Sciot R; van Damme B; de Wolf-Peeters C; Desmet VJ
    Virchows Arch A Pathol Anat Histopathol; 1987; 412(1):63-72. PubMed ID: 2446418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.
    Gonzalez-Quintela A; García J; Campos J; Perez LF; Alende MR; Otero E; Abdulkader I; Tomé S
    Alcohol; 2006 Jan; 38(1):45-9. PubMed ID: 16762691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275.
    Chedid A; Mendenhall CL; Moritz TE; French SW; Chen TS; Morgan TR
    Am J Gastroenterol; 1993 Nov; 88(11):1920-7. PubMed ID: 7694454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorganisation of intermediate filament structure in alcoholic and other liver diseases.
    Barbatis C; Morton J; Woods JC; Burns J; Bradley J; McGee JO
    Gut; 1986 Jul; 27(7):765-70. PubMed ID: 3732887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR expression in bile duct damage in hepatitis C.
    Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN
    Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial hepatectomy and bile duct ligation in rainbow trout (Oncorhynchus mykiss): histologic, immunohistochemical and enzyme histochemical characterization of hepatic regeneration and biliary hyperplasia.
    Okihiro MS; Hinton DE
    Toxicol Pathol; 2000; 28(2):342-56. PubMed ID: 10805153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcoholic liver disease. Parenchyma to stroma relationship in fibrosis and cirrhosis as revealed by three-dimensional reconstruction and immunohistochemistry.
    Dinges HP; Zatloukal K; Denk H; Smolle J; Mair S
    Am J Pathol; 1992 Jul; 141(1):69-83. PubMed ID: 1378697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Mallory bodies and an attempt to demonstrate cell mediated immunity to Mallory body isolate in patients with alcoholic liver disease.
    Gluud C; Hardt F; Aldershvile J; Christoffersen P; Lyon H; Nielsen J
    J Clin Pathol; 1981 Sep; 34(9):1010-6. PubMed ID: 6168660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranous expression of Lewis Y antigen in clustered hepatocytes in chronic viral, autoimmune, and alcoholic liver diseases but not in biliary diseases.
    Sasaki M; Kono N; Nakanuma Y
    Mod Pathol; 1994 Apr; 7(3):339-46. PubMed ID: 8058706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.